Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme

Progress in the treatment of glioblastoma multiforme (GBM) over the last few decades has remained marginal and GBM is still universally fatal with short survival times after initial diagnosis. Much research is focused on finding new therapeutics for GBM and immune-based approaches have shown great p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuessler, Andrea, Walker, David G., Khanna, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187613/
https://www.ncbi.nlm.nih.gov/pubmed/25340042
http://dx.doi.org/10.3389/fonc.2014.00275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187613/
https://www.ncbi.nlm.nih.gov/pubmed/25340042
http://dx.doi.org/10.3389/fonc.2014.00275

Ejemplares similares